Stolper Co Has $2.01 Million Stake in CVS Health Co. (NYSE:CVS)

Stolper Co trimmed its stake in CVS Health Co. (NYSE:CVS – Get Rating) by 16.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,585 shares of the pharmacy operator’s stock after selling 4,339 shares during the period. Stolper Co’s holdings in CVS Health were worth $2,012,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BRYN MAWR TRUST Co increased its holdings in CVS Health by 1.5% in the second quarter. BRYN MAWR TRUST Co now owns 6,459 shares of the pharmacy operator’s stock valued at $598,000 after purchasing an additional 98 shares during the period. Cobblestone Capital Advisors LLC NY increased its holdings in CVS Health by 3.3% in the third quarter. Cobblestone Capital Advisors LLC NY now owns 3,136 shares of the pharmacy operator’s stock valued at $299,000 after purchasing an additional 100 shares during the period. IFG Advisors LLC increased its holdings in CVS Health by 4.0% in the third quarter. IFG Advisors LLC now owns 2,667 shares of the pharmacy operator’s stock valued at $254,000 after purchasing an additional 102 shares during the period. First National Trust Co boosted its position in CVS Health by 2.9% during the third quarter. First National Trust Co now owns 3,640 shares of the pharmacy operator’s stock valued at $347,000 after acquiring an additional 104 shares during the last quarter. Finally, Pinnacle Wealth Planning Services Inc. boosted its position in CVS Health by 1.0% during the third quarter. Pinnacle Wealth Planning Services Inc. now owns 10,025 shares of the pharmacy operator’s stock valued at $956,000 after acquiring an additional 104 shares during the last quarter. 77.29% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 1.9 %

NYSE CVS traded down $1.46 during trading hours on Friday, hitting $74.37. The company’s stock had a trading volume of 16,807,803 shares, compared to its average volume of 9,656,588. CVS Health Co. has a 52 week low of $73.91 and a 52 week high of $109.69. The company has a market capitalization of $95.50 billion, a PE ratio of 23.84, a price-to-earnings-growth ratio of 1.17 and a beta of 0.65. The company has a current ratio of 0.94, a quick ratio of 0.67 and a debt-to-equity ratio of 0.71. The company’s 50-day simple moving average is $85.40 and its two-hundred day simple moving average is $93.04.

CVS Health (NYSE:CVS – Get Rating) last posted its quarterly earnings data on Wednesday, February 8th. The pharmacy operator reported $1.99 EPS for the quarter, beating the consensus estimate of $1.92 by $0.07. The firm had revenue of $83.85 billion during the quarter, compared to analyst estimates of $76.37 billion. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $1.98 EPS. Research analysts anticipate that CVS Health Co. will post 8.84 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 1st. Shareholders of record on Friday, April 21st will be paid a $0.605 dividend. The ex-dividend date of this dividend is Thursday, April 20th. This represents a $2.42 annualized dividend and a yield of 3.25%. CVS Health’s dividend payout ratio (DPR) is 77.56%.

Analyst Ratings Changes

A number of analysts have commented on the stock. Raymond James cut their price target on shares of CVS Health from $115.00 to $110.00 and set an “outperform” rating on the stock in a research report on Thursday, February 9th. Morgan Stanley upped their price target on shares of CVS Health from $119.00 to $120.00 and gave the company an “overweight” rating in a research report on Friday, January 13th. StockNews.com began coverage on shares of CVS Health in a research report on Thursday. They set a “buy” rating on the stock. Jefferies Financial Group increased their price objective on shares of CVS Health from $130.00 to $143.00 and gave the stock a “buy” rating in a research report on Thursday, February 9th. Finally, Credit Suisse Group increased their price objective on shares of CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, November 21st. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $119.65.

About CVS Health

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.